XML 28 R13.htm IDEA: XBRL DOCUMENT v3.20.2
STOCKHOLDERS' EQUITY
3 Months Ended
Sep. 30, 2020
Equity [Abstract]  
STOCKHOLDERS' EQUITY STOCKHOLDERS EQUITY
Changes in the components of Stockholders’ equity were as follows for the periods indicated:
Three Months Ended September 30
(Dollars in millions except per share data; shares in thousands)
Common StockAdditional Paid-in CapitalRetained EarningsTreasury StockAccumulated
Other
Comprehensive
Net (Loss) Income
Non-controlling interests
Total Stockholders Equity
AmountSharesAmountShares
Balance as of June 30, 2019$159 158,741 $1,046 $3,150 $(3,194)(33,055)$(602)$— $559 
Cumulative effect of accounting changes, net of tax (1)
22 22 
Net earnings203 203 
Other comprehensive (loss) income(13)(13)
Dividends to Clorox stockholders ($1.06 per share declared)
(134)(134)
Stock-based compensation
Other employee stock plan activities(9)— 20 472 11 
Treasury stock purchased(104)(663)(104)
Balance as of September 30, 2019$159 158,741 $1,043 $3,241 $(3,278)(33,246)$(615)$— $550 
Balance as of June 30, 2020$159 158,741 $1,137 $3,567 $(3,315)(32,543)$(640)$— $908 
Net earnings415 417 
Other comprehensive (loss) income17 17 
Dividends to Clorox stockholders ($1.11 per share declared)
(141)(141)
Dividends to noncontrolling interests(4)(4)
Business combinations including purchase accounting adjustments198 198 
Stock-based compensation13 13 
Other employee stock plan activities(4)(1)283 
Treasury stock purchased(100)(444)(100)
Balance as of September 30, 2020$159 158,741 $1,146 $3,840 $(3,407)(32,704)$(623)$196 $1,311 

(1) As a result of adopting ASU No. 2016-02, “Leases (Topic 842),” on July 1, 2019, the Company recorded a cumulative effect of initially applying the new guidance as an adjustment to the fiscal year 2020 opening balance of Retained earnings.

The Company has two stock repurchase programs: an open-market purchase program with an authorized aggregate purchase amount of up to $2,000, which has no expiration date, and a program to offset the anticipated impact of dilution related to stock-based awards (the Evergreen Program), which has no authorization limit on the dollar amount and no expiration date.

Stock repurchases under the two stock repurchase programs were as follows for the periods indicated:
Three Months Ended
9/30/20209/30/2019
AmountShares
(in thousands)
AmountShares
(in thousands)
Open-market purchase program$— — $— — 
Evergreen Program100 444 104 663 
Total stock repurchases$100 444 $104 663 
Changes in Accumulated other comprehensive net (loss) income attributable to Clorox by component were as follows for the periods indicated:
Three Months Ended September 30
Foreign currency translation adjustmentsNet unrealized gains (losses) on derivativesPension and postretirement benefit adjustmentsAccumulated other comprehensive net (loss) income
Balance as of June 30, 2019$(414)$(23)$(165)$(602)
Other comprehensive (loss) income before reclassifications(15)— (14)
Amounts reclassified from Accumulated other comprehensive net (loss) income— 
Income tax benefit (expense)(1)(1)(1)(3)
Net current period other comprehensive (loss) income(16)(13)
Balance as of September 30, 2019$(430)$(21)$(164)$(615)
Balance as of June 30, 2020$(450)$(18)$(172)$(640)
Other comprehensive (loss) income before reclassifications— 12 
Amounts reclassified from Accumulated other comprehensive net (loss) income— 
Income tax benefit (expense), and other(1)— — 
Net current period other comprehensive (loss) income10 17 
Balance as of September 30, 2020$(440)$(13)$(170)$(623)

Included in foreign currency translation adjustments are re-measurement losses on long-term intercompany loans where settlement is not planned or anticipated in the foreseeable future. There were no amounts associated with these loans reclassified from Accumulated other comprehensive net (loss) income for the periods presented.